| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.03 | 0.6 |